Breaking News Instant updates and real-time market news.

AMC

AMC Entertainment

$14.10

-0.35 (-2.42%)

, RGC

Regal Entertainment

06:44
01/08/18
01/08
06:44
01/08/18
06:44

AMC, Cinemark, Regal Q4 EPS targets reduced on soft box office at Loop Capital

Loop Capital analyst David Miller lowers his Q4 EPS targets on AMC Entertainment (AMC) to 28c from 39c, on Cinemark (CNK) to 40c from 52c, and on Regal Entertainment (RGC) to 33c from 47c. Miller cites the Q4 U.S. Box Office growth of just 2.8%, below his prior view of 8%-10% which assumed stronger sales given blockbuster titles "such as Blade Runner 2049, Thor 3, Coco, Justice League, Murder on the Orient Express , and of course Star Wars Episode 8". The analyst keeps his respective Buy, Buy, and Hold rating on the three stocks.

AMC

AMC Entertainment

$14.10

-0.35 (-2.42%)

RGC

Regal Entertainment

CNK

Cinemark

$34.17

0.18 (0.53%)

  • 09

    Jan

AMC AMC Entertainment
$14.10

-0.35 (-2.42%)

08/07/17
MKMP
08/07/17
NO CHANGE
MKMP
AMC Entertainment 'big picture' outlook still positive, says MKM Partners
After AMC issued a disappointing preannouncement, MKM Partners analyst Eric Handler blames the miss on Carmike weakness. However, the analyst says that AMC should be boosted over the longer term by "newly instituted cost cuts, ongoing renovation efforts and non-strategic asset sales." He keeps a $28 price target and Buy rating.
09/15/17
LOOP
09/15/17
NO CHANGE
LOOP
AMC Entertainment has multiple positive catalysts, says Loop Capital
After meeting with AMC's management, Loop Capital analyst David Miller reports that AMC "has largely fixed" the problems that caused theaters formerly owned by Carmike to underperform in 1H17. Miller quotes AMC's CEO as saying that "the non-renovated Carmike theaters are performing in line with the non-renovated AMC theaters." Miller remains skeptical as to whether premium video on demand will ever launch, and he says that AMC should benefit from easy comps in 2H17 as well as a strong movie slate for the "next five quarters." He says that the stock represents an "exceptional opportunity" for deep value investors. He keeps a $33 price target and a Buy rating on the shares.
09/11/17
SBSH
09/11/17
NO CHANGE
Target $21
SBSH
Buy
AMC Entertainment risk/reward attractive after selloff, says Citi
Citi analyst Jason Bazinet attributes to the decline in 2017 of AMC Entertainment shares to $13 from $31 to fears over windowing, uncertainty about Wanda financing, concerns over leverage as well as the a weaker box office. The analyst sees an attractive risk/reward at current share levels, noting his base case suggests the stock is worth $21. His bull case suggests the equity could reach $32. Bazinet cut his price target for AMC shares to $21 from $30 and keeps a Buy rating on the name.
01/02/18
MKMP
01/02/18
NO CHANGE
Target $26
MKMP
Buy
AMC Entertainment has highest 2018 potential in cinema, says MKM Partners
MKM Partners analyst Eric Handler keeps his Buy rating and $26 price target on AMC Entertainment, saying the company has the highest potential for return within the expected rebound in the Cinema industry this year. Handler notes the company's drivers including Odeon and Carmike reseating initiatives, organic growth from newly opened Nordic theatres, savings from last year's cost-cutting efforts, and the possibility of an IPO for assets in Europe.
RGC Regal Entertainment

01/02/18
RILY
01/02/18
DOWNGRADE
Target $23
RILY
Neutral
Regal Entertainment downgraded to Neutral from Buy at B. Riley FBR
B. Riley FBR analyst Eric Wold downgraded Regal Entertainment to Neutral and lowered his price target for the shares to $23 from $24.75. The analyst sees a more balanced risk/reward as the end of the go-shop period approaches.
12/20/17
JPMS
12/20/17
NO CHANGE
JPMS
JPMorgan 'relatively favorable' on movie theaters into 2018
JPMorgan analyst Julia Yue expects improved, although still volatile, box office trends heading into 2018. Cinemark (CNK) and Regal Entertainment (RGC) shares will likely be affected by short-term performance and larger secular fears from any premium-video-on-demand headlines, Yue told investors in a research note detailing her sector outlook for 2018. The analyst has an Overweight rating on Cinemark and Neutral rating on Regal. She's "relatively favorable" on the movie theaters going into next year and projects EBITDA growth, market share gains, and potential further consolidation will drive growth and better share performance. Risks to the companies include MoviePass, of which Helios and Matheson (HMNY) owns a 52% stake, Netflix (NFLX) and higher film rents, Yue contends. The analyst notes MoviePass pays full retail price to the exhibitors for each consumer and sustains the difference between retail price payments to the exhibitors and incoming revenue from its subscribers as a loss. She believes, however, that the service has the potential to change consumers' perceptions of the value of a movie ticket longer term. Over the near term, Yue views the subscription service positively for the exhibitors saying it could drive incremental attendance and concession purchases. Longer term, however, MoviePass could have negative implications for the movie theatres if it were to gain enough subscribers to demand better economics, Yue writes.
12/06/17
RBCM
12/06/17
DOWNGRADE
Target $23
RBCM
Sector Perform
Regal Entertainment downgraded to Sector Perform from Outperform at RBC Capital
RBC Capital analyst Leo Kulp downgraded Regal Entertainment to Sector Perform from Outperform and kept his $23 price target following the announcement that the company will be acquired by Cineworld. Kulp says he sees a "high probability the deal goes through" as the only potential hurdle is the Cineworld shareholder vote. While a competing bid can emerge, Kulp notes, there is little evidence to suggest this scenario.
12/06/17
MOFT
12/06/17
UPGRADE
MOFT
Neutral
Regal Entertainment upgraded to Neutral from Sell at MoffettNathanson
CNK Cinemark
$34.17

0.18 (0.53%)

12/05/17
MAXM
12/05/17
NO CHANGE
Target $25
MAXM
Buy
Helios selloff on Cinemark news a buying opportunity, says Maxim
Maxim analyst Brian Kinstlinger views today's selloff in Helios and Matheson Analytics (HMNY) on news of Cinemark's (CNK) monthly subscription offering as a buying opportunity. The stock in afternoon trading is down 20%, or $2.41, to $9.62. Cinemark's offer "provides only modest relief in ticket pricing and essentially locks-in the consumer to see movies only at Cinemark theaters," Kinstlinger tells investors in a research note. He feels MoviePass' offering, at $9.95 per month for unlimited movies to almost any theater, is a "much better value." Separately, the analyst thinks MoviePass, which is 52% owned by Helios and Matheson, has crossed 1M subscribers based on the fact that the annual discounted promotion announced in mid-November is no longer on its website. Kinstlinger keeps a Buy rating on Helios and Matheson with a $25 price target.
10/05/17
MSCO
10/05/17
UPGRADE
Target $38
MSCO
Equal Weight
Cinemark upgraded to Equal Weight from Underweight at Morgan Stanley
Morgan Stanley analyst Benjamin Swinburne upgraded Cinemark to Equal Weight from Underweight, noting that the shares have lagged the market by 16% year-to-date due to a disappointing domestic summer box office and ongoing concerns around Premium Video on Demand. With recent box office results better than expected, he has raised his Q4 box office growth estimate to 15% from a prior view of up 10%. However, citing his revised 2018 domestic box office forecast of up 1%, down from a prior call for a 5% increase, the analyst lowered his price target on Cinemark to $38 from $40.
12/05/17
LOOP
12/05/17
NO CHANGE
Target $47
LOOP
Buy
Cinemark club a response to MoviePass, but not a loss leader, says Loop Capital
Loop Capital analyst David Miller said Cinemark's (CNK) subscription "Movie Club" is "clearly an answer" to MoviePass, but unlike the latter Cinemark's offering is not intended to be a loss leader and is priced to produce operating income. Miller, who thinks MoviePass' offer is not sustainable but that Cinemark's program should lead to incremental profits, keeps a Buy rating and $47 price target on Cinemark shares. Helios and Matheson Analytics (HMNY) previously has announced that it has agreed to purchase a majority stake in MoviePass.

TODAY'S FREE FLY STORIES

03:05
01/22/18
01/22
03:05
01/22/18
03:05
General news
FX Update: The dollar dipped at the open of Asia-Pacific dealings »

FX Update: The dollar…

02:55
01/22/18
01/22
02:55
01/22/18
02:55
Conference/Events
Morgan Stanley transportation analysts hold an analyst/industry conference call »

ASEAN Transportation VP…

FCX

Freeport McMoRan

$19.96

0.56 (2.89%)

21:10
01/21/18
01/21
21:10
01/21/18
21:10
Downgrade
Freeport McMoRan rating change at CIBC »

Freeport McMoRan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

DCM

NTT DoCoMo

$24.74

0.08 (0.32%)

21:09
01/21/18
01/21
21:09
01/21/18
21:09
Downgrade
NTT DoCoMo rating change at HSBC »

NTT DoCoMo downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAL

Halliburton

$53.01

0.65 (1.24%)

, PETS

PetMed Express

$53.24

2.67 (5.28%)

20:25
01/21/18
01/21
20:25
01/21/18
20:25
Earnings
Notable companies reporting before Monday's open »

Notable companies…

HAL

Halliburton

$53.01

0.65 (1.24%)

PETS

PetMed Express

$53.24

2.67 (5.28%)

OPB

Opus Bank

$28.70

0.05 (0.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

FB

Facebook

$181.29

1.49 (0.83%)

, NYT

New York Times

$21.90

1.7 (8.42%)

20:00
01/21/18
01/21
20:00
01/21/18
20:00
Hot Stocks
On The Fly: Top five weekend stock stories »

Catch up on the…

FB

Facebook

$181.29

1.49 (0.83%)

NYT

New York Times

$21.90

1.7 (8.42%)

NWSA

News Corp.

$17.22

0.21 (1.23%)

FOXA

21st Century Fox

$36.65

0.47 (1.30%)

AMZN

Amazon.com

$1,294.58

1.26 (0.10%)

AAPL

Apple

$178.46

-0.8 (-0.45%)

NFLX

Netflix

$220.46

0.13 (0.06%)

SNE

Sony

$49.89

0.72 (1.46%)

BA

Boeing

$337.73

-2.43 (-0.71%)

WMT

Walmart

$104.59

0.29 (0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 23

    Jan

  • 30

    Jan

  • 31

    Jan

  • 31

    Jan

  • 01

    Feb

  • 01

    Feb

  • 07

    Feb

  • 07

    Feb

  • 20

    Feb

  • 21

    Feb

  • 28

    Feb

  • 18

    Mar

XRX

Xerox

$31.80

0.43 (1.37%)

19:18
01/21/18
01/21
19:18
01/21/18
19:18
Periodicals
Icahn, Deason pushing for Xerox to explored sale, WSJ reports »

Carl Icahn and Darwin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$181.29

1.49 (0.83%)

18:22
01/21/18
01/21
18:22
01/21/18
18:22
Periodicals
Facebook to open three new digital training hubs in Europe, Reuters says »

Facebook said it will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 31

    Jan

  • 07

    Feb

  • 28

    Feb

TWX

Time Warner

$93.36

0.39 (0.42%)

, CMCSA

Comcast

$42.50

0.65 (1.55%)

17:56
01/21/18
01/21
17:56
01/21/18
17:56
Hot Stocks
Box Office Battle: 'Jumanji' wins weekend with $20M »

Once again, Sony's…

TWX

Time Warner

$93.36

0.39 (0.42%)

CMCSA

Comcast

$42.50

0.65 (1.55%)

CMCSK

Comcast

SNE

Sony

$49.89

0.72 (1.46%)

FOX

21st Century Fox

$36.26

0.53 (1.48%)

FOXA

21st Century Fox

$36.65

0.47 (1.30%)

LGF.A

Lionsgate

$35.42

0.92 (2.67%)

DIS

Disney

$110.59

0.17 (0.15%)

VIAB

Viacom

$33.36

-0.59 (-1.74%)

VIA

Viacom

$39.20

-0.5 (-1.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 24

    Jan

  • 06

    Feb

  • 07

    Feb

  • 07

    Feb

  • 08

    Feb

  • 08

    Feb

  • 08

    Feb

CTIC

CTI BioPharma

16:11
01/21/18
01/21
16:11
01/21/18
16:11
Conference/Events
CTI BioPharma to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

ZSAN

Zosano Pharma

$0.45

-0.0387 (-7.92%)

16:00
01/21/18
01/21
16:00
01/21/18
16:00
Conference/Events
Zosano Pharma to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SANM

Sanmina

$35.45

0.5 (1.43%)

15:39
01/21/18
01/21
15:39
01/21/18
15:39
Conference/Events
Sanmina to hold a conference call »

Management holds an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,294.58

1.26 (0.10%)

12:05
01/21/18
01/21
12:05
01/21/18
12:05
Periodicals
Amazon automated grocery store opens Monday, Reuters says »

Amazon will open its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

  • 18

    Mar

TWTR

Twitter

$23.66

-0.38 (-1.58%)

09:07
01/21/18
01/21
09:07
01/21/18
09:07
Periodicals
Twitter COO in discussions to become SoFi CEO, WSJ reports »

Twitter's COO,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 07

    Feb

  • 08

    Feb

  • 28

    Feb

CLF

Cleveland-Cliffs

$8.49

0.08 (0.95%)

09:02
01/21/18
01/21
09:02
01/21/18
09:02
Hot Stocks
Cleveland-Cliffs addresses ''inaccurate media reports' on Nashwauk property »

Cleveland-Cliffs said it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

BMY

Bristol-Myers

$62.28

0.45 (0.73%)

15:26
01/20/18
01/20
15:26
01/20/18
15:26
Hot Stocks
Opdivo, Yervoy combo demonstrates activity in patients with dMMR, MSI-H mCRC »

Bristol-Myers Squibb…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 05

    Feb

  • 08

    Feb

  • 05

    Mar

  • 08

    Mar

EXEL

Exelixis

$28.00

0.14 (0.50%)

, RHHBY

Roche

$30.69

0.18 (0.59%)

15:22
01/20/18
01/20
15:22
01/20/18
15:22
Hot Stocks
Exelixis presents updated results from Phase 1b clinical trial in CRC »

Exelixis (EXEL) announced…

EXEL

Exelixis

$28.00

0.14 (0.50%)

RHHBY

Roche

$30.69

0.18 (0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 01

    Feb

  • 08

    Feb

  • 15

    Feb

  • 23

    Feb

ARRY

Array BioPharma

$13.14

0.26 (2.02%)

15:17
01/20/18
01/20
15:17
01/20/18
15:17
Hot Stocks
Array BioPharma updates results from BEACON Phase 3 trial »

Array BioPharma and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jun

  • 30

    Jun

SO

Southern Company

$44.44

-0.46 (-1.02%)

15:13
01/20/18
01/20
15:13
01/20/18
15:13
Hot Stocks
Southern Company accelerates restoration efforts in Puerto Rico »

Southern Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TECK

Teck Resources

$29.43

0.19 (0.65%)

15:10
01/20/18
01/20
15:10
01/20/18
15:10
Hot Stocks
Teck Resources announces Elkview incident »

Teck Resources announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

TWTR

Twitter

$23.66

-0.38 (-1.58%)

14:03
01/20/18
01/20
14:03
01/20/18
14:03
Hot Stocks
Twitter begins notifying users exposed to Russian propaganda during elections »

Twitter, which is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 07

    Feb

  • 08

    Feb

  • 28

    Feb

SPY

SPDR S&P 500 ETF Trust

$280.41

1.27 (0.45%)

, SPX

S&P 500

13:58
01/20/18
01/20
13:58
01/20/18
13:58
Periodicals
Government shuts down on anniversary of Trump presidency, Reuters reports »

President's Trump…

SPY

SPDR S&P 500 ETF Trust

$280.41

1.27 (0.45%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$181.29

1.49 (0.83%)

, NYT

New York Times

$21.90

1.7 (8.42%)

13:48
01/20/18
01/20
13:48
01/20/18
13:48
Periodicals
NY Times stock jumps after Facebook's announcement, Recode reports »

Facebook (FB) CEO Mark…

FB

Facebook

$181.29

1.49 (0.83%)

NYT

New York Times

$21.90

1.7 (8.42%)

NWSA

News Corp.

$17.22

0.21 (1.23%)

FOXA

21st Century Fox

$36.65

0.47 (1.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 31

    Jan

  • 07

    Feb

  • 07

    Feb

  • 28

    Feb

WMT

Walmart

$104.59

0.29 (0.28%)

13:36
01/20/18
01/20
13:36
01/20/18
13:36
Periodicals
Still time to shop Walmart shares as company makes changes, Barron's says »

In a follow-up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

AAPL

Apple

$178.46

-0.8 (-0.45%)

, NFLX

Netflix

$220.46

0.13 (0.06%)

08:59
01/20/18
01/20
08:59
01/20/18
08:59
Periodicals
Netflix among likely candidates for an Apple purchase, Barron's says »

Especially for tech…

AAPL

Apple

$178.46

-0.8 (-0.45%)

NFLX

Netflix

$220.46

0.13 (0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 30

    Jan

  • 01

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.